Loading...

Nanomedicines in the treatment of acromegaly: focus on pegvisomant

This article examines the role of pegvisomant in the treatment of acromegaly. This syndrome, caused by excessive growth hormone (GH) secretion by a pituitary adenoma, is associated with a doubled mortality rate and poor quality of life. Pituitary microsurgery has long been the first choice of treatm...

Full description

Saved in:
Bibliographic Details
Main Authors: Roelfsema, Ferdinand, Biermasz, Nienke R, Pereira, Alberto M, Romijn, Johannes M
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2006
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2676637/
https://ncbi.nlm.nih.gov/pubmed/17722273
Tags: Add Tag
No Tags, Be the first to tag this record!